Table 2.
OR of baseline cognitive and motor scores for dalfampridine responders.
| PR | FR | OR | 95% CI | p | |
|---|---|---|---|---|---|
| 37 | 34 | ||||
| PASAT 3 raw, mean (SD) | 26.35 (11.26) | 30.79 (14.46) | 1.03 | 0.99–1.07 | 0.152 |
| PASAT 3 adjusted, mean (SD) | −1.53 (0.93) | −1.16 (1.19) | 1.39 | 0.89–2.19 | 0.152 |
| T25-FWT, mean (SD) | 8.04 (2.96) | 6.63 (1.86) | 0.76 | 0.60–0.98 | 0.033 |
| 9HPT dominant hand, mean (SD) | 29.26 (14.25) | 22.97 (6.33) | 0.92 | 0.86–0.99 | 0.029 |
| 9HPT no dominant hand, mean (SD) | 29.48 (10.47) | 25.75 (8.44) | 0.96 | 0.90–1.01 | 0.117 |
| MSFC | −0.40 (1.96) | 0.79 (1.99) | 1.37 | 1.05–1.80 | 0.022 |
p values refer to univariate logistic regression.
9HPT, 9-Hole Peg Test; CI, confidence interval; FR, fully responders; MSFC, Multiple Sclerosis Functional Composite; OR, odds ratio; PASAT, Paced Auditory Serial Addition Test; PR, partially responders; T25-FWT, Timed 25-Foot Walk Test.